Matthew Shair, Director at Nuvalent, Inc. (NUVL), sold 3,121 shares at $102.29 ($320K) on 2024-09-23, disclosed to the SEC on 2024-09-25.
Scheduled sale ($320k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.34 | 356 | $36K | 11.3% |
| 2 | $102.29 | 1,121 | $115K | 35.8% |
| 3 | $102.29 | 1,121 | $115K | 35.8% |
| 4 | $103.16 | 101 | $10K | 3.3% |
| 5 | $104.54 | 230 | $24K | 7.5% |
| 6 | $105.36 | 163 |
| $17K |
| 5.4% |
| 7 | $106.50 | 6 | $639 | 0.2% |
| 8 | $107.82 | 23 | $2K | 0.8% |
| Total | $102.58 avg | 3,121 | $320K | 100% |
| Filing → |
| NUVL | SELL | 2025-02-25 | $265K | — | Filing → |
| NUVL | SELL | 2025-01-29 | $302K | — | Filing → |
| NUVL | SELL | 2024-12-26 | $285K | — | Filing → |